Carbapenemase-producing Enterobacteriaceae in Irish critical care units: Results of a pilot prevalence survey, June 2011

Journal of Hospital Infection

Volumn 83, Issue 1, 2013, Pages 71-73

  Burns, K ^a,c,d   Morris, D ^b   Murchan, S ^a   Cunney, R ^a   Smyth, E ^c   Power, M ^d   Schaffer, K ^e   Collins, C ^f   Sheahan, A ^d   Cormican, M ^b   Fitzpatrick, F ^a,c,d  

^a HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c BEAUMONT HOSPITAL   (Ireland)

^d HEALTH SERVICE EXECUTIVE   (Ireland)

^e ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^f TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Carbapenemases; Critical care; Rectal colonization

Indexed keywords

CARBAPENEMASE;

ADULT; ARTICLE; BACTERIUM DETECTION; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CHILD; ENTEROBACTERIACEAE; HEALTH SURVEY; HUMAN; INTENSIVE CARE; IRELAND; MAJOR CLINICAL STUDY; PILOT STUDY; PRACTICE GUIDELINE; PREVALENCE; RECTUM;

BACTERIAL PROTEINS; BETA-LACTAMASES; CARRIER STATE; CRITICAL CARE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; INTENSIVE CARE UNITS; IRELAND; MASS SCREENING; PILOT PROJECTS; PREVALENCE; RECTUM;

EID: 84870996495     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.09.015     Document Type: Article

References (14)

1. Patel G., Huprikar S., Factor S.H., Jenkins S.G., Calfee D.P. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008, 29:1099-1106.
2. Roche C., Cotter M., O'Connell N., Crowley B. First identification of class A carbapenemase-producing Klebsiella pneumoniae in the Republic of Ireland. Eurosurveill 2009, 14:4-5.
3. Burns K., Schaffer K. CRE update issued on laboratory detection and infection control measures. EpiInsight 2011, 12. News item number 6.
4. Centers for Disease Control and Prevention. Guidance for control of carbapenem-resistant Enterobacteriaceae (CRE): 2012 CRE toolkit. Atlanta, GA: CDC.
5. Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement. M100-S21 2011, Clinical Laboratory Standards Institute, CLSI, Wayne, PA.
6. Woodford N., Tierno P.M., Young K., et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolysing class A β lactamase, KPC-3, in a New York medical center. Antimicrob Agents Chemother 2004, 48:4793-4799.
7. Dallenne C., Da Costa A., Cecre D., Favier C., Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important β lactamases in Enterobacteriaceae. J Antimicrob Chemother 2010, 65:490-495.
8. Woodford N. Rapid characterisation of beta-lactamases by multiplex PCR. Antibiotic resistance protocols 2010, Humana Press, New York. 2nd ed. S.H. Gillespie, T.D. McHugh (Eds.).
9. Nordmann P., Poirel L., Carrer A., Toleman M., Walsh T.R. How to detect NDM-1 producers. J Clin Microbiol 2011, 49:718-721.
10. Nordmann P., Naas T., Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011, 17:1791-1798.
11. Prior A.R., Roche C., Lynch M., Kelly S., O'Rourke K., Crowley B. First identified case of VIM-producing carbapenem resistant Klebsiella pneumoniae in the Republic of Ireland associated with fatal outcome. Eurosurveill 2010, 15:25.
12. O'Brien D.J., Wrenn C., Roche C., et al. First isolation and outbreak of OXA-48-producing Klebsiella pneumoniae in an Irish hospital, March to June 2011. Eurosurveill 2011, 16:4-6.
13. McDermott H., Morris D., McArdle E., et al. Isolation of NDM-1-producing Klebsiella pneumoniae in Ireland, July 2011. Eurosurveill 2012, 17. pii=20087.
14. Queenan A.M., Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007, 20:440-458.